Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Journal of Consulting and Clinical Psychology|April 7, 2004
Reducing HIV-risk behavior among adults receiving outpatient psychiatric treatment: results from a randomized controlled trialMichael P Carey, Kate B Carey, Stephen A Maisto, et al.The Journal of Nervous and Mental Disease|April 3, 2004
HIV risk behavior among psychiatric outpatients: association with psychiatric disorder, substance use disorder, and genderMichael P Carey, Kate B Carey, Stephen A Maisto, et al.Investigational New Drugs|August 25, 2000
A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413)J S Macdonald, J L Jacobson, M Modiano, et al.Urologic Oncology|June 22, 2001
Phase II evaluation of suramin in advanced renal cell carcinoma. A Southwest Oncology Group studyL E. Schroder, D Lew, R C. Flanigan, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 1998
Rhenium-188(Sn)HEDP for treatment of osseous metastasesH R Maxon, L E Schroder, L C Washburn, et al.The Journal of Rheumatology|March 1, 1996
Uric acid lowering effect of oxipurinol sodium in hyperuricemic patients - therapeutic equivalence to allopurinolI Walter-Sack, J X de Vries, B Ernst, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1991
Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placeboH R Maxon, L E Schroder, V S Hertzberg, et al.Translational Behavioral Medicine|January 14, 2015
Control condition design and implementation features in controlled trials: a meta-analysis of trials evaluating psychotherapy for depressionDavid C Mohr, Joyce Ho, Tae L Hart, et al.Seminars in Nuclear Medicine|January 1, 1992
Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastasesH R Maxon, S R Thomas, V S Hertzberg, et al.Cancer Chemotherapy and Pharmacology|November 7, 1999
Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic studyS M Grunberg, J Crowley, K R Hande, et al.Pageof 5